CS logo
small CS logo
MUDr. GREGAR s.r.o.

Olomouc, Czechia
Gastroenterologická ambulance v Olomouci

About MUDr. GREGAR s.r.o.


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at MUDr. GREGAR s.r.o.


During the past decade, MUDr. GREGAR s.r.o. conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 5 clinical trials were completed, i.e. on average, 35.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 5 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "MUDr. GREGAR s.r.o." #1 sponsor was "Eli Lilly and Company" with 7 trials, followed by "Abivax S.A." with 2 trials sponsored, "Celgene" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Janssen Research & Development, LLC" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "MUDr. GREGAR s.r.o." #1 collaborator was "Nektar Therapeutics" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at MUDr. GREGAR s.r.o.


According to Clinical.Site data, the most researched conditions in "MUDr. GREGAR s.r.o." are "Ulcerative Colitis" (8 trials), "Crohn's Disease" (4 trials), "Colitis, Ulcerative" (1 trials) and "Crohn Disease" (1 trials). Many other conditions were trialed in "MUDr. GREGAR s.r.o." in a lesser frequency.

Clinical Trials Intervention Types at MUDr. GREGAR s.r.o.


Most popular intervention types in "MUDr. GREGAR s.r.o." are "Drug" (14 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Mirikizumab" (5 trials), "RPC1063" (2 trials), "ABX464" (1 trials) and "ABX464 100mg" (1 trials). Other intervention names were less common.

Clinical Trials Genders at MUDr. GREGAR s.r.o.


The vast majority of trials in "MUDr. GREGAR s.r.o." are 14 trials for "All" genders.

Clinical Trials Status at MUDr. GREGAR s.r.o.


Currently, there are NaN active trials in "MUDr. GREGAR s.r.o.". undefined are not yet recruiting, 3 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in MUDr. GREGAR s.r.o., undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in MUDr. GREGAR s.r.o., 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".